E4CPG 25 mg | 99.96%
TargetMol
E4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.
More Information Supplier PageE4CPG
Search Results
E4CPG 10 mg | 99.96%
TargetMol
E4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.
More Information Supplier PageE4CPG
E4CPG 100 mg | 99.96%
TargetMol
E4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.
More Information Supplier PageE4CPG
Naloxegol oxalate 5 mg | 99.82%
TargetMol
Naloxegol oxalate is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation.
More Information Supplier PageNaloxegol oxalate
Naloxegol oxalate 50 mg | 99.82%
TargetMol
Naloxegol oxalate is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation.
More Information Supplier PageNaloxegol oxalate
(RS)-MCPG 10 mg | Purity Not Available
TargetMol
(RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.
More Information Supplier Page(RS)-MCPG
(RS)-MCPG 25 mg | Purity Not Available
TargetMol
(RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.
More Information Supplier Page(RS)-MCPG
Formosanin C 5 mg | 100.00%
TargetMol
Formosanin C (Polyphyllin B) is a compound isolated from Rhizoma Paridis, showed pro-apoptosis and immunoregulation with antitumor activity in cultured cells and animal systems.
More Information Supplier PageFormosanin C
PD-166866 5 mg | 99.98%
TargetMol
PD-166866
PD-166866 50 mg | 99.98%
TargetMol
PD-166866